Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Prineo (Dermabond Protape) Versus Sutures for Full-thickness Surgical Incisions: Complete Statistical AnalysisIndependent statistical analysis of Prineo (Dermabond Protape) Versus Sutures for Full-thickness Surgical Incisions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00557947).
- Prineo Sensitivity Dressing Study: Complete Statistical AnalysisIndependent statistical analysis of Prineo Sensitivity Dressing Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06011603).
- PRINTOJDMTRIndependent statistical analysis of Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00323960).
- PRIORAIndependent statistical analysis of A Trial to Evaluate the Safety and Tolerability of Namilumab (MT203) in Patients With Mild to Moderate Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size…
- PRIORITIIndependent statistical analysis of A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.: primary endpoint results,…
- PRIORITI-MTFIndependent statistical analysis of PRIORITI-MTF Study- Testing Patient Response to the IDEO: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02158884).
- PRIORITIZEIndependent statistical analysis of Study of Oral Treatments for Hepatitis C: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02786537).
- PRISMIndependent statistical analysis of Case Review of the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PRISMIndependent statistical analysis of Efficacy and Safety Study of I10E in Treatment of Patients With CIDP: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PRISMIndependent statistical analysis of Perceptions of Cigarette Smoking in Young Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03953508).
- PRISMIndependent statistical analysis of Pain Research: Innovative Strategies With Marijuana: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03522324).
- PRiSMIndependent statistical analysis of Patient Response to Spinal Manipulation - Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01562756).
- PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer): Complete Statistical AnalysisIndependent statistical analysis of PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PRISM-ACIndependent statistical analysis of The PRISM Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults With Advanced Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Prismaflex HF20 Set and Prismaflex® System 7.10/7.20 for Acute Continuous Renal Replacement Therapy (CRRT) in Children: Complete Statistical AnalysisIndependent statistical analysis of Prismaflex HF20 Set and Prismaflex® System 7.10/7.20 for Acute Continuous Renal Replacement Therapy (CRRT) in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- PRKIndependent statistical analysis of Comparison of Cross-cylinder and Conventional Photorefractive Keratectomy(PRK) in Correcting Medium-high Astigmatism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PRMRP-FPA2Independent statistical analysis of Iterative Design of Custom Dynamic Orthoses to Reduce Articular Contact Stress: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PRMRP-NormsIndependent statistical analysis of Iterative Design of Custom Dynamic Orthoses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04800510).
- PRNIndependent statistical analysis of Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PRO 140 in Treatment-Experienced HIV-1 Subjects: Complete Statistical AnalysisIndependent statistical analysis of PRO 140 in Treatment-Experienced HIV-1 Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03902522).
- PRO SoloIndependent statistical analysis of Participant-Reported Outcomes With the Accu-Chek® Solo Micropump System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03478969).
- PRO-037Independent statistical analysis of Clinical Trial to Evaluate the Safety and Tolerability of Lagricel® Ofteno Multi-dose Ophthalmic Solution: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PRO-087/IIndependent statistical analysis of Safety and Tolerability of PRO-087 Versus Xyel Ofteno® and Systane Ultra®, on the Ocular Surface of Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- PRO-148Independent statistical analysis of Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- PRO-149Independent statistical analysis of Study to Evaluate the Safety of the Viscoelastic Substance PRO-149, Compared to Healon® EndoCoat.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PRO-165Independent statistical analysis of Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PRO-201Independent statistical analysis of Phase I Clinical Trial to Evaluate the Safety and Tolerability of Ophtalmic Solution PRO-201: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PRO-DEFENSEIndependent statistical analysis of Study of Sedative Medications in Patients With Severe Infection and Respiratory Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PRO-HFIndependent statistical analysis of Patient-Reported Outcome Measurement in Heart Failure Clinic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04164004).
- PRO-POWER: Hypertension With Risk Factors for a Duration of 24 Weeks With Micardis 80mg/Micardis Plus 80mg/12.5mg: Complete Statistical AnalysisIndependent statistical analysis of PRO-POWER: Hypertension With Risk Factors for a Duration of 24 Weeks With Micardis 80mg/Micardis Plus 80mg/12.5mg: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- PRO-SCALPIndependent statistical analysis of A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of…
- ProACTIndependent statistical analysis of ProACT Therapy for the Treatment of Stress Urinary Incontinence in Males: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PROACTIVEIndependent statistical analysis of PRV-015 in Gluten-free Diet Non-responsive Celiac Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04424927).
- Probability Ramp Control of Propofol for EGD: Complete Statistical AnalysisIndependent statistical analysis of Probability Ramp Control of Propofol for EGD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01838304).
- Probe Based Confocal Laser Endomicroscopy During Thoracoscopy for Pleural Malignancies Diagnosis.: Complete Statistical AnalysisIndependent statistical analysis of Probe Based Confocal Laser Endomicroscopy During Thoracoscopy for Pleural Malignancies Diagnosis.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Probing Cortical Excitability and Cognitive Function With TMS: Complete Statistical AnalysisIndependent statistical analysis of Probing Cortical Excitability and Cognitive Function With TMS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03652012).
- PROBIOLACIndependent statistical analysis of Global Effects of a Probiotic Strain on Lactating Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01124448).
- Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor: Complete Statistical AnalysisIndependent statistical analysis of Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor: primary endpoint results, effect estimate with confidence…
- Probiotics as Adjuvant Treatment for Bacterial Vaginosis: Complete Statistical AnalysisIndependent statistical analysis of Probiotics as Adjuvant Treatment for Bacterial Vaginosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03894813).
- Problem-Solving Skills Training to Improve Care for Children With Asthma: Complete Statistical AnalysisIndependent statistical analysis of Problem-Solving Skills Training to Improve Care for Children With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00250588).
- ProBPIndependent statistical analysis of Clinical Trial of Dietary Protein and Blood Pressure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00046566).
- ProBPIndependent statistical analysis of Clinical Trial of Protein and Blood Pressure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00107744).
- Procalcitonin-Guided Decision Making to Shorten Antibiotic Therapy in Suspected Neonatal Early-Onset Sepsis: Complete Statistical AnalysisIndependent statistical analysis of Procalcitonin-Guided Decision Making to Shorten Antibiotic Therapy in Suspected Neonatal Early-Onset Sepsis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PROCEEDIndependent statistical analysis of Effect of a Patient-Centered Decision App on TOLAC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02646423).
- PROCLAIMIndependent statistical analysis of the PROCLAIM phase 3 trial, including its randomized design, overall survival analysis, progression-free survival, response, relapse patterns, swallowing outcomes, safety, statistical methods, and interpretation.
- PROCLAIMIndependent statistical analysis of Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Proclear 1-D Multifocal Nondispensing Study: Complete Statistical AnalysisIndependent statistical analysis of Proclear 1-D Multifocal Nondispensing Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01526902).
- PROCLIVITY02Independent statistical analysis of HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01856023).
- PRODIndependent statistical analysis of Prospective Randomized Controlled Trial of Obstructed Defecation Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05747027).
- PRODEIndependent statistical analysis of Prognosis of Depression in the Elderly (PRODE). A Multicentre, Longitudinal Study of Elderly Depressed Patients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…